RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 81 filers reported holding RECRO PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,000 | 0.0% | 1,790 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | +25.0% | 1,790 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -73.3% | 1,790 | -44.3% | 0.00% | – |
| Q2 2020 | $15,000 | -44.4% | 3,212 | -4.2% | 0.00% | – |
| Q1 2020 | $27,000 | -64.9% | 3,352 | -20.5% | 0.00% | – |
| Q4 2019 | $77,000 | +126.5% | 4,214 | +36.2% | 0.00% | – |
| Q3 2019 | $34,000 | +13.3% | 3,093 | 0.0% | 0.00% | – |
| Q2 2019 | $30,000 | +66.7% | 3,093 | 0.0% | 0.00% | – |
| Q1 2019 | $18,000 | -18.2% | 3,093 | 0.0% | 0.00% | – |
| Q4 2018 | $22,000 | 0.0% | 3,093 | 0.0% | 0.00% | – |
| Q3 2018 | $22,000 | +120.0% | 3,093 | +52.7% | 0.00% | – |
| Q2 2018 | $10,000 | -54.5% | 2,026 | 0.0% | 0.00% | – |
| Q1 2018 | $22,000 | +15.8% | 2,026 | 0.0% | 0.00% | – |
| Q4 2017 | $19,000 | +5.6% | 2,026 | 0.0% | 0.00% | – |
| Q3 2017 | $18,000 | +28.6% | 2,026 | 0.0% | 0.00% | – |
| Q2 2017 | $14,000 | – | 2,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |